Cannabis research encompasses a broad spectrum of scientific inquiry into the effects, uses, and potential risks associated with cannabis and its constituents. With increasing legalization and decriminalization efforts worldwide, there has been a surge in research aimed at understanding the pharmacology, therapeutic applications, and public health implications of cannabis use. Studies explore various aspects of cannabis, including its active compounds such as tetrahydrocannabinol (THC) and cannabidiol (CBD), their mechanisms of action within the body, and their impact on neurological, psychological, and physiological functions.
Research into cannabis spans diverse fields, including medicine, psychology, pharmacology, neuroscience, and public health. Investigations focus on the therapeutic potential of cannabis and its derivatives in managing conditions such as chronic pain, epilepsy, multiple sclerosis, and psychiatric disorders. Additionally, researchers examine the effects of cannabis on cognitive function, mental health outcomes, addiction, driving impairment, and the development of regulatory frameworks to mitigate potential risks associated with cannabis use. Through rigorous scientific inquiry, cannabis research aims to provide evidence-based insights that inform policy, medical practice, and public health interventions related to cannabis legalization and regulation.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States